262 related articles for article (PubMed ID: 11174372)
1. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
[TBL] [Abstract][Full Text] [Related]
3. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
5. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
[TBL] [Abstract][Full Text] [Related]
7. Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma.
Hagiwara K; Khaskhely NM; Uezato H; Nonaka S
J Dermatol; 1999 Sep; 26(9):577-86. PubMed ID: 10535252
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
[TBL] [Abstract][Full Text] [Related]
11. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of Spindle Cell Vascular Tumors.
Marušić Z; Billings SD
Surg Pathol Clin; 2017 Jun; 10(2):345-366. PubMed ID: 28477885
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Ets-1 transcription factor in angiosarcoma of the skin.
Naito S; Shimizu K; Nakashima M; Nakayama T; Ito T; Ito M; Yamashita S; Sekine I
Pathol Res Pract; 2000; 196(2):103-9. PubMed ID: 10707367
[TBL] [Abstract][Full Text] [Related]
14. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
15. A series of vascular tumors and tumorlike lesions of the bladder.
Tavora F; Montgomery E; Epstein JI
Am J Surg Pathol; 2008 Aug; 32(8):1213-9. PubMed ID: 18580491
[TBL] [Abstract][Full Text] [Related]
16. The histiocytoid hemangiomas and other controversies.
Allen PW; Ramakrishna B; MacCormac LB
Pathol Annu; 1992; 27 Pt 2():51-87. PubMed ID: 1584628
[TBL] [Abstract][Full Text] [Related]
17. Expression of PROX-1 in oral Kaposi's sarcoma spindle cells.
Benevenuto de Andrade BA; Ramírez-Amador V; Anaya-Saavedra G; Martínez-Mata G; Fonseca FP; Graner E; Paes de Almeida O
J Oral Pathol Med; 2014 Feb; 43(2):132-6. PubMed ID: 23763431
[TBL] [Abstract][Full Text] [Related]
18. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
Johnson EF; Davis DM; Tollefson MM; Fritchie K; Gibson LE
Am J Dermatopathol; 2018 Apr; 40(4):231-239. PubMed ID: 29561329
[TBL] [Abstract][Full Text] [Related]
19. Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin.
Kuhn A; Brachtendorf G; Kurth F; Sonntag M; Samulowitz U; Metze D; Vestweber D
J Invest Dermatol; 2002 Dec; 119(6):1388-93. PubMed ID: 12485444
[TBL] [Abstract][Full Text] [Related]
20. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities.
Chan JK; Frizzera G; Fletcher CD; Rosai J
Am J Surg Pathol; 1992 Apr; 16(4):335-50. PubMed ID: 1373579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
